World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
122
Citations
78023
World Ranking
3409
National Ranking
339

Overview

Christopher P. Day is affiliated with Newcastle University in the United Kingdom and has contributed extensively to the field of medicine, with a specific focus on liver-related diseases. Their research encompasses epidemiology, pathology, endocrinology, hepatology, and respiratory medicine, reflecting a multidisciplinary approach to health sciences.

The primary areas of study for Christopher P. Day include:

  • Epidemiology
  • Pathology and Forensic Medicine
  • Endocrinology, Diabetes and Metabolism
  • Hepatology
  • Pulmonary and Respiratory Medicine

The scientist's work addresses key topics such as:

  • Liver Disease Diagnosis and Treatment
  • Diet, Metabolism, and Disease
  • Alcohol Consumption and Health Effects
  • Lipid Metabolism and Disorders
  • Liver Disease and Transplantation
  • Endoplasmic Reticulum Stress and Disease
  • Diabetes and Associated Disorders

Christopher P. Day has co-authored research with several frequent collaborators, notably:

  • Ann K. Daly
  • Heather J. Cordell
  • Rebecca Darlay
  • Guruprasad P. Aithal
  • Quentin M. Anstee

Their publications have appeared predominantly in the Journal of Hepatology, among other journals such as bioRxiv (Cold Spring Harbor Laboratory), UNC Libraries, Science Translational Medicine, and Nature Metabolism.

Significant recent publications include:

  • "Genome-wide association study of non-alcoholic fatty liver and steatohepatitis in a histologically characterised cohort," 2020, Journal of Hepatology
  • "Transcriptomic profiling across the nonalcoholic fatty liver disease spectrum reveals gene signatures for steatohepatitis and fibrosis," 2020, Science Translational Medicine
  • "An unbiased ranking of murine dietary models based on their proximity to human metabolic dysfunction-associated steatotic liver disease (MASLD)," 2024, Nature Metabolism
  • "Performance of non-invasive tests and histology for the prediction of clinical outcomes in patients with non-alcoholic fatty liver disease: an individual participant data meta-analysis," 2023, The Lancet. Gastroenterology & Hepatology
  • "Macrophage scavenger receptor 1 mediates lipid-induced inflammation in non-alcoholic fatty liver disease," 2021, Journal of Hepatology

Best Publications

  • Steatohepatitis: a tale of two "hits"?

    Christopher P. Day;Oliver F.W. James

  • EASL-EASD-EASO Clinical Practice Guidelines for the Management of Non-Alcoholic Fatty Liver Disease

    Giulio Marchesini;Christopher P. Day;Jean Francois Dufour;Ali Canbay

  • The NAFLD fibrosis score: A noninvasive system that identifies liver fibrosis in patients with NAFLD

    Paul Angulo;Jason M. Hui;Giulio Marchesini;Ellisabetta Bugianesi

  • Risk of Cardiovascular Disease in Patients with Nonalcoholic Fatty Liver Disease

    Giovanni Targher;Christopher P. Day;Enzo Bonora

  • QT dispersion: an indication of arrhythmia risk in patients with long QT intervals.

    C. P. Day;J. M. Mccomb;R. W. F. Campbell

  • Modeling NAFLD Disease Burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016-2030

    Chris Estes;Quentin M. Anstee;Maria Teresa Arias-Loste;Heike Bantel

  • Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis.

    Quentin M. Anstee;Giovanni Targher;Christopher P. Day

  • Association of polymorphisms in the cytochrome P450 CYP2C9 with warfarin dose requirement and risk of bleeding complications

    Guruprasad P Aithal;Christopher P Day;Patrick J L Kesteven;Ann K Daly

  • Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease.

    Luca Miele;Venanzio Valenza;Giuseppe La Torre;Massimo Montalto

  • Prevalence of Nonalcoholic Fatty Liver Disease and Its Association With Cardiovascular Disease Among Type 2 Diabetic Patients

    Giovanni Targher;Lorenzo Bertolini;Roberto Padovani;Stefano Rodella

  • A position statement on NAFLD/NASH based on the EASL 2009 special conference ☆

    Vlad Ratziu;Stefano Bellentani;Helena Cortez-Pinto;Chris Day

  • The natural history of nonalcoholic fatty liver: A follow-up study

    Mohd R. Teli;Oliver F. W. James;Alastair D. Burt;Mark K. Bennett

  • Cause, Pathogenesis, and Treatment of Nonalcoholic Steatohepatitis

    Anna M Diehl;Christopher Day

  • HLA-B*5701 genotype is a major determinant of drug-induced liver injury due to flucloxacillin.

    Ann K Daly;Peter T Donaldson;Pallav Bhatnagar;Yufeng Shen

  • Evidence of NAFLD progression from steatosis to fibrosing-steatohepatitis using paired biopsies: Implications for prognosis and clinical management

    Stuart McPherson;Stuart McPherson;Tim Hardy;Elsbeth Henderson;Alastair D. Burt;Alastair D. Burt

  • Non-alcoholic fatty liver disease: The mist gradually clears

    Nimantha Mark Wilfred de Alwis;Christopher Paul Day

  • Simple non-invasive fibrosis scoring systems can reliably exclude advanced fibrosis in patients with non-alcoholic fatty liver disease

    Stuart McPherson;Stephen F Stewart;Elsbeth Henderson;Alastair D Burt

  • Noninvasive markers of fibrosis in nonalcoholic fatty liver disease: Validating the European Liver Fibrosis Panel and exploring simple markers.

    Indra Neil Guha;Julie Parkes;Paul Roderick;Dipanker Chattopadhyay

  • Cellular senescence drives age-dependent hepatic steatosis.

    Mikolaj Ogrodnik;Satomi Miwa;Tamar Tchkonia;Dina Tiniakos;Dina Tiniakos

  • Nonalcoholic fatty liver disease

    Elizabeth M. Brunt;Vincent W.-S. Wong;Valerio Nobili;Christopher P. Day

Frequent Co-Authors

Ann K. Daly
Ann K. Daly Newcastle University
Alastair D. Burt
Alastair D. Burt Newcastle University
Quentin M. Anstee
Quentin M. Anstee Newcastle University
Guruprasad P. Aithal
Guruprasad P. Aithal University of Nottingham
David Jones
David Jones Newcastle University
Elisabetta Bugianesi
Elisabetta Bugianesi University of Turin
Oliver F. W. James
Oliver F. W. James Newcastle University
Emanuele Albano
Emanuele Albano University of Eastern Piedmont Amadeo Avogadro
Margaret F. Bassendine
Margaret F. Bassendine Newcastle University
Heather J. Cordell
Heather J. Cordell Newcastle University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a medical career in the USA offers a variety of educational pathways beyond the traditional MD route. Many students and professionals are now considering alternative healthcare degrees that can be completed online, which provide both flexibility and affordability.

For registered nurses seeking career advancement, enrolling in the phd in nursing program can open doors to leadership, research, and teaching roles. Similarly, the cheapest rn to bsn program online makes it possible for working RNs to earn a bachelor’s degree at minimal cost, increasing their qualifications and earning potential.

For non-nurses interested in moving quickly into advanced roles, direct msn programs online provide a fast-track to a Master’s in Nursing—even without prior nursing experience. Those seeking to begin their careers sooner may explore adn programs, which offer a quicker entry point into the workforce as a registered nurse.

Exploring these online degrees and related career paths can offer more accessible and varied opportunities for those passionate about working in healthcare.

Best Scientists Citing Christopher P. Day

Trending Scientists

Recently Published Articles